1. Russell DJ, Wright M, Rosenbaum PL, Avery LM. Gross Motor Function Measure (GMFM-66 & GMFM-88) user’s manual. 3rd ed. Mac Keith Press;2021. p. 1-320.
2. Wei S, Su-Juan W, Yuan-Gui L, Hong Y, Xiu-Juan X, Xiao-Mei S. Reliability and validity of the GMFM-66 in 0- to 3-year-old children with cerebral palsy. Am J Phys Med Rehabil. 2006; 85:141–7.
Article
3. Russell DJ, Rosenbaum PL, Lane M, Gowland C, Goldsmith CH, Boyce WF, et al. Training users in the Gross Motor Function Measure: methodological and practical issues. Phys Ther. 1994; 74:630–6.
Article
4. Ko J, Kim M. Inter-rater reliability of the K-GMFM-88 and the GMPM for children with cerebral palsy. Ann Rehabil Med. 2012; 36:233–9.
Article
5. Palisano RJ, Walter SD, Russell DJ, Rosenbaum PL, Gémus M, Galuppi BE, et al. Gross motor function of children with down syndrome: creation of motor growth curves. Arch Phys Med Rehabil. 2001; 82:494–500.
Article
6. Russell D, Palisano R, Walter S, Rosenbaum P, Gemus M, Gowland C, et al. Evaluating motor function in children with Down syndrome: validity of the GMFM. Dev Med Child Neurol. 1998; 40:693–701.
Article
7. Linder-Lucht M, Othmer V, Walther M, Vry J, Michaelis U, Stein S, Gross Motor Function Measure-Traumatic Brain Injury Study Group, et al. Validation of the Gross Motor Function Measure for use in children and adolescents with traumatic brain injuries. Pediatrics. 2007; 120:e880–6.
Article
8. Ruck-Gibis J, Plotkin H, Hanley J, Wood-Dauphinee S. Reliability of the Gross Motor Function Measure for children with osteogenesis imperfecta. Pediatr Phys Ther. 2001; 13:10–7.
Article
9. Sato T, Adachi M, Nakamura K, Zushi M, Goto K, Murakami T, et al. The Gross Motor Function Measure is valid for Fukuyama congenital muscular dystrophy. Neuromuscul Disord. 2017; 27:45–9.
Article
10. Nelson L, Owens H, Hynan LS, Iannaccone ST; AmSMART Group. The Gross Motor Function Measure is a valid and sensitive outcome measure for spinal muscular atrophy. Neuromuscul Disord. 2006; 16:374–80.
Article
11. Wright BScPT M, Fairfield SM. Adaptation and psychometric properties of the Gross Motor Function Measure for children receiving treatment for acute lymphoblastic leukemia. Rehabil Oncol. 2007; 25:14–20.
Article
12. Rosenbaum PL, Walter SD, Hanna SE, Palisano RJ, Russell DJ, Raina P, et al. Prognosis for gross motor function in cerebral palsy: creation of motor development curves. JAMA. 2002; 288:1357–63.
Article
13. Avery LM, Russell DJ, Rosenbaum PL. Criterion validity of the GMFM-66 item set and the GMFM-66 basal and ceiling approaches for estimating GMFM-66 scores. Dev Med Child Neurol. 2013; 55:534–8.
14. Salavati M, Rameckers EA, Waninge A, Krijnen WP, Steenbergen B, van der Schans CP. Gross motor function in children with spastic cerebral palsy and cerebral visual impairment: a comparison between outcomes of the original and the cerebral visual impairment adapted Gross Motor Function Measure-88 (GMFM-88-CVI). Res Dev Disabil. 2017; 60:269–76.
Article
15. Storm FA, Petrarca M, Beretta E, Strazzer S, Piccinini L, Maghini C, et al. Minimum clinically important difference of gross motor function and gait endurance in children with motor impairment: a comparison of distribution-based approaches. Biomed Res Int. 2020; 2020:2794036.
Article
16. Oeffinger D, Bagley A, Rogers S, Gorton G, Kryscio R, Abel M, et al. Outcome tools used for ambulatory children with cerebral palsy: responsiveness and minimum clinically important differences. Dev Med Child Neurol. 2008; 50:918–25.
Article
17. Wang HY, Yang YH. Evaluating the responsiveness of 2 versions of the Gross Motor Function Measure for children with cerebral palsy. Arch Phys Med Rehabil. 2006; 87:51–6.
Article